Monoclonal Antibodies Against EGFR, HER2, and VEGF: Mechanistic Insights and Emerging Strategies in Targeted Cancer Therapy
Monoclonal antibodies (mAbs) that target receptor-mediated oncogenic pathways have revolutionized oncology research. Better therapeutic indices are possible with these mAbs for targeted tumor treatment. This review covers receptor-targeted monoclonal antibodies targeting the EGFR, HER2, and VEGF pathways in solid t...